NCT03402386 - Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 3, 2018

Primary Completion Date

November 22, 2018

Study Completion Date

December 20, 2018

Conditions

Anemia; Peritoneal Dialysis Dependent Chronic Kidney Disease

Interventions

DRUG

MT-6548

Oral tablet

Trial Locations (17)

Research site, Aichi

Research site, Chiba

Research site, Fukuoka

Research site, Fukushima

Research site, Gunma

Research site, Hokkaido

Research site, Hyōgo

Research site, Ibaraki

Research site, Kagoshima

Research site, Kanagawa

Research site, Kyoto

Research site, Nagano

Research site, Nara

Research site, Okayama

Research site, Okinawa

Research site, Shiga

Research site, Tokyo